This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Autoimmune Polyendocrinopathy Syndrome, Type 1
Information about Autoimmune Polyendocrinopathy Syndrome, Type 1: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Autoimmune Polyendocrinopathy Syndrome, Type 1
Most recent studies have shown that Autoimmune Polyendocrinopathy Syndrome, Type 1 shares some biological mechanisms with addison-disease, adrenal-gland-hypofunction, autoimmune-diseases, autoimmune-reaction, autoimmunity, candidiasis, candidiasis-chronic-mucocutaneous, diabetes-mellitus, diabetes-mellitus-insulin-dependent, dystrophy, endocrine-system-diseases, hepatitis, hepatitis-autoimmune, hypoparathyroidism, hypothyroidism, oral-candidiasis, polyendocrinopathies-autoimmune, polyglandular-type-i-autoimmune-syndrome.
Among the many pathways, these few ones have gauged particular interests from scientists studying Autoimmune Polyendocrinopathy Syndrome, Type 1, and have been seen in publications frequently: Amelogenesis, Cell Development, Cell Proliferation, Cytokine Production, Developmental Process, Endochondral Ossification, Glomerular Filtration, Humoral Immune Response, Immune Response, Insulin Secretion, Localization, Methylation, Ossification, Pathogenesis, Pigmentation, Regulation Of Gene Expression, T Cell Homeostasis, T Cell Proliferation, T Cell Selection, Translation
Quite a number of genes have been found to play important roles in Autoimmune Polyendocrinopathy Syndrome, Type 1, such as AIRE, CHAT, CREBBP, CYP11A1, FOXP3, GAD2, GH1, GLUL, IL1RN, IL2RA, IL7, INS, KLK3, NUDT11, PTH, SH2B2, SLC10A3, TAC1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.